Research Report on In Vitro Diagnostics Technologies and Global Markets

1
Research Report on In Vitro Diagnostics
Technologies and Global Markets
2

The global market for in vitro diagnostics (IVD)
products was totaled at 57.3 billion in 2014. It
is expected to grow from 60.3 billion in 2015 to
81.1 billion by 2020 at a compound annual growth
rate (CAGR) of 6.1 from 2015 to 2020. This
report provides -An overview of the global
markets and related technologies for in vitro
diagnostics -Analyses of global market trends,
with data from 2014, estimates for 2015, and
projections of compound annual growth rates
(CAGRs) through 2020 -Detailed coverage of
application areas, end users, and factors
influencing and inhibiting demand for
IVD Information about IVD products including
reagents, instruments, and data management
softwares and services
3

-A look at how the rise in the number of diseases
like respiratory infections, hospital acquired
infections (HAI), and sexually transmitted
diseases are creating a constant need for
infectious disease testing both in hospitals and
laboratories -Segmentation into immunochemistry,
clinical chemistry, SMBG, POC, MDx, hematology,
microbiology, hemostasis and tissue
diagnostics -Geographical breakdowns -Application
analysis Diabetes, infectious, oncology,
cardiology, neurology and others. -Profiles of
major players in the industry
4

INTRODUCTION
STUDY GOALS AND OBJECTIVES This report offers a
comprehensive analysis of the global in-vitro
diagnostic market, along with an in-depth study
of the various IVD segments (clinical chemistry,
immunoassays, point-of-care diagnostics,
molecular diagnostics, hematology, microbiology
and tissue diagnostics) products (instruments,
reagents and accessory products) end-user groups
(central labs, critical care, OTC/self-testing
and academia) and the regional markets of North
America, Europe, Asia and LAAM (Latin
America/Africa/Middle East).
5
This report provides a complete review and
analysis of the current trends in the IVD
markets, along with industry growth drivers and
restraints. Revenues are broken down by regions,
segments, products and end users, and sales
figures have been estimated for the five-year
period from 2015 through 2020 in constant U.S.
dollars. In addition, it provides an examination
and description of select products, current and
emerging technologies, and company profiles.
Applications for IVD are also discussed, with
emphasis of the use of these types of tests in
various disease sectors. Further, the report
offers a view on IVD patents, regulatory aspects
and emerging developments in the IVD market
across the globe.
6
REASONS FOR DOING THIS STUDY In vitro diagnostic
tests performed on biological samples, such as
blood, urine, saliva, spinal fluid and DNA, are a
key component of health care delivery. The
information provided by IVD tests enable medical
care providers to manage several diseases through
timely prevention, diagnosis and decision making,
and by administering patient-specific treatment
modalities. Due to recent rapid technological
advances and automation, the range and complexity
of diagnostic tests have overwhelmingly
increased. This has made lab tests much easier to
use and less error prone, with more precise and
timelier results, thus transforming medical
practice.
7
As a result of these rapid innovations, disease
detection has been made possible much before the
appearance of symptoms, along with the prediction
of beneficial and adverse treatment outcomes.
These developments have in turn enabled
personalized treatment through the emergence of
point-of-care (POC) tests and home-based testing
in the form of blood glucose meters for
diabetics, pregnancy tests and cholesterol tests.
These tests facilitate more rapid
decision-making, especially for management of
major chronic diseases such as diabetes,
hypertension or cardiovascular conditions.
Instead of a patient having to wait for test
results and schedule his or her next visit, test
values for key biochemical parameters (such as,
for example, HbA1c or lipid profiles), are
generated the same day, allowing a doctor to make
treatment decisions during the same visit.
8
In addition, new tests have become less invasive,
easier to perform and more patient friendly.
Likewise, for critical care, POC tests enable
doctors to make life-saving decisions within
minutes, as opposed to waiting for hours for test
data that was once available only from a central
lab. Today, more than 4,000 different diagnostic
tests have become available, and as more IVD
tests become compatible with POC environments,
health care providers should take advantage of
the benefits of these evolving IVDs for effective
treatment of life-threatening illnesses through
optimization of healthcare delivery. IVDs have
already tremendously impacted cancer diagnosis
and treatment globally by gaining deeper insights
into genetic pathways of the disease enabled by
human genome sequencing. As a result, identifying
faulty genes, personalized risk predictions and
tailored therapies have now become possible.
9
Big challenges need to be addressed, however,
despite IVDs being at the top of global market
attractiveness index. The regional and
country-wise differences in regulatory aspects,
market approvals and entry bottlenecks,
affordability issues, reimbursement inadequacies,
logistics and healthcare infrastructure may hold
the market back. Due to these factors, the IVD
companies need to look at each countrys market
landscape and IVD requirements, and then tailor
their entries, launch and marketing strategies to
gain a strong foot hold. This BCC Research
report, In Vitro Diagnostics Technologies and
Global Markets, will thereby provide a detailed
analysis of these and other key factors governing
the growth of IVD industry, and provide strategic
insights and recommendations for those looking to
expand their markets.
10
CONTRIBUTION OF THE STUDY AND FOR WHOM The
intended audience includes all the stakeholders
of the IVD market diagnostic test manufacturing
companies, disposable vendors, reagent suppliers,
start-ups, technology and business incubators,
venture capital firms, hospitals, diagnostic
labs, physician offices and groups, university
research groups and other involved participants.
With its broad scope and in-depth analyses, this
study is a valuable resource to anyone involved
with or interested in the development and
promotion of IVD technologies. Since this study
provides business and technical information of a
timely nature, it will prove valuable to a
variety of readers, including industry
executives, managers and planners, purchasers,
industry analysts and investors. The projections,
forecasts and trend analyses found in this report
provide readers with the necessary data and
information for careful decision-making and
products that will best meet the needs of the IVD
segment.
11
SCOPE OF REPORT The scope of this study is
global. This Report on analyzes each market and
its applications, regulatory environment,
technologies involved, market projections and
market shares. The emerging markets discussed
include countries such as India, China, Korea,
Taiwan, Africa, Australia, Brazil and Russia,
among others. The report also examines the IVD
market drivers as well as restraints and
challenges affecting its growth. Further, the
report also highlights the emerging products and
technologies and associated start-ups that are
likely to accelerate the growth of the IVD
industry through their best practices in the
research and development of IVDs. Excluded from
this study are diagnostic testing such as
imaging, veterinary diagnostics and their
associated products.
12
This study will provide information on these
areas -Structure and current market size of the
IVD market as outlined with forecasts through
2020. -Impact of chronic diseases, growing and
aging populations. -Current technology and
product suppliers and key innovations. -A look at
the IVD industry and trends affecting the
market. -Markets by each segment
(immunochemistry, molecular diagnostics, POC
tests, clinical microbiology, hematology and
tissue diagnostics) provide a global overview
showing market data for the U.S., Europe, Asia
and LAAM regions. -Emerging opportunities and
potential investment opportunity areas for
IVD. -Technology patent trends relating to
IVD. -Profiles for more than 20 companies in the
industry with significant contributions and
market shares.
13
METHODOLOGY Information for this report was
derived from a variety of primary and secondary
research sources, including industry analysts,
annual reports and Securities and Exchange
Commission (SEC) reports, the United Network for
Organ Sharing (UNOS), the Organ Procurement and
Transplantation Network (OPTN), the Scientific
Registry of Transplant Recipients (SRTR), the
Center for Medicare and Medicaid Services (CMS),
the National Institutes of Health (NIH), the
Centers for Disease Control (CDC), other
government agencies and journal articles.
Secondary sources include literature searches,
product literature and press releases. When
precise information was not available, a
consensus was made using reasonable assumptions
and estimates based on historical data. Data were
collected through interviews and correspondence
with IVD industry experts. Projections were based
on estimates and information based on historical
revenue trends in subsegments, validations
through primary research, mergers and
acquisitions, and market trends.
14
Table of Contents

• Introduction - Complimentary 4 0
• Global Market Trends
• Market Landscape
• Global Ivd Market By Subcategories
• Global Immunochemistry Market 8 375
  Applications
• Global Poc Testing Market 8 375 Applications
• Global Hematology Market 7 328 Applications
• Global Molecular Diagnostics Market 13 609
  Applications
• Global Clinical Microbiology Market 5 234
  Applications
• Global Tissue Diagnostics Market 6 281
  Applications

W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com
15
To view the full Executive Summary and Table
of Contents, please visit Research Report on
In Vitro Diagnostics Technologies and Global
Markets Contact Us-Call India
91-22-27810772/73Email id info_at_bharatbook.com
Website www.bharatbook.com Our Blog
https//www.bharatbook.com/blog/

W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com